2015 Speakers

  • speaker

    Nadeem Sarwar VP & Head, Genetics & Human Biology Eisai Nadeem’s research focuses on applying genetics and related quantitative and translational sciences. Nadeem joined Eisai from Pfizer, where he was Senior Director, Head of Population Research & Cardiometabolic Genetics. Prior to working in industry, Nadeem was tenured faculty at the University of Cambridge (UK).

  • speaker

    Kiran Reddy Associate Partner Third Rock Ventures

  • Edward Boyden Co-Director MIT Center for Neurobiological Engineering

  • Kees Been CEO & President Lysosomal Therapeutics

  • Peter Bergethon Head of Computational Neuromedicine & Exploratory Human Biology Pfizer Peter R. Bergethon is the head of the Computational Neuromedicine and Human Biology line in the Neuroscience Research Unit in WRD. Read more...

  • Alastair Brown Head of Pharmacology Heptares Therapeutics

  • speaker

    Gabriel Vargas Executive Medical Director Amgen

  • Nellie Byun Principal Investigator Vanderbilt Center for Neuroscience Drug Discovery

  • Daniel Chain CEO CereSpir

  • Vaibhav Diwadkar Co-Director Brain Imaging Research Division Wayne State University

  • Jim Doherty VP, Pharmacology Sage Therapeutics

  • speaker

    Dario Doller Director, Discovery Chemistry & DMPK Lundbeck

  • Craig Ferris Director, Centre for Neurotranslational Imaging Northeastern University Dr. Ferris received his bachelor's degree in biology from the University of Massachusetts and his doctorate in physiology from New York Medical College. Read more...

  • Samuel Gandy Director Mount Sinai Center for Cognitive Health and NFL Ne

  • Thomas Hudzik Associate Director Abbvie

  • Johanne Kaplan VP, Neuroimmunology Research Genzyme

  • Hao Wang Program Director National Institute of Neurological Disorders and Stroke, NIH

  • Paul McGonigle Head, Drug Discovery & Development Program Drexel University

  • Spyros Papapetropoulos Global Clinical Leader, Neuroscience Pfizer

  • Mary Ann Pelleymounter Scientific Project Manager National Institute of Neurological Disorders and Stroke, NIH

  • Diana Price Director, Biosciences Neuropore Therapeutics

  • Sanjay Rakhade Clinical Director, Clinical Development Genzyme

  • Evan Snyder Professor Sanford-Burnham Medical Research Institute

  • Xue Han Peter Paul Career Development Professor & Assistant Professor Boston University Dr. Xue Han is a Peter Paul Career Development Professor and an assistant professor of Biomedical Engineering at Boston University. Her neuroengineering lab is developing radical new genetic, molecular, and optical neurotechnologies and application protocols to treat neurological and psychiatric diseases. Read more...